Linzagolix
Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei Pharmaceutical and ObsEva for the treatment of uterine fibroids, endometriosis, and adenomyosis.
Product Specifications
CAS Number
935283-04-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
508.42
Molecular Formula
C22H15F3N2O7S
Notes
Research use only, not for human use.
Receptor
Antibacterial
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
128150-APC 100 µL
TRMT112 (tRNA Methyltransferase 112 Homolog, TRM112-like Protein, AD-001, HSPC152, HSPC170) (APC)
Sign In for Pricing
View Details 
